Trademark: 97858204
Status Date
Tuesday, December 26, 2023
Filing Date
Monday, March 27, 2023
Published for Opposition
Tuesday, October 31, 2023
5 Injectable pharmaceutical preparations comprising erodible ingredients that facilitate the delivery of pharmaceuticals via injection into the posterior segment of the eye for the treatment of eye diseases and conditions of the retina, namely, wet age-related macular degeneration, non-proliferative diabetic retinopathy, diabetic macular edema and retinal vein occlusion and excluding dry eye, conjunctivitis, glaucoma and bacterial eye infections
Dec 26, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 29, 2023
Changes/Corrections After Pub Approval Entered
Nov 27, 2023
Assigned To Petition Staff
Nov 27, 2023
Assigned To Petition Staff
Oct 31, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 31, 2023
Published For Opposition
Oct 23, 2023
Teas Post Publication Amendment Received
Oct 11, 2023
Notification Of Notice Of Publication E-Mailed
Sep 22, 2023
Approved For Pub - Principal Register
Sep 21, 2023
Assigned To Examiner
Apr 18, 2023
New Application Office Supplied Data Entered
Mar 30, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
